We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
NanoViricides has reached an agreement on the terms of the license for the drug development against VZV, the virus that causes chickenpox in children and shingles in adults....